(Q56593674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Morgan G

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Dalley D

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Kelly PJ

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 August 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

87-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Potential role of tamoxifen in prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Tamoxifen as a potential preventive agent in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Bone mineral content of women receiving tamoxifen for mastalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Effects of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

ESTIMATION OF HYDROXYPROLINE BY THE AUTOANALYSER.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Age and menopause-related changes in indices of bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Effects of a short course of estrogen on mineral metabolism in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Thromboembolic risk of tamoxifen in patients with stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980220-6

7 January 2021

10.1016/S0169-6009(08)80220-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251768%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference